What's New
LucenceINSIGHT® — Muti-Cancer Early Screening
2026.8.14
LucenceINSIGHT® is a next-generation sequencing multi-cancer early detection (MCED) blood test designed to effectively identify early-stage cancers. Its key advantages include:
-
99% specificity
(significantly reducing false positives)
-
81% sensitivity
-
88% tumor localization accuracy
-
100% positive predictive value
-
No fasting is required before sample collection. However, please avoid heavy meals 4 hours prior to the test. It is recommended to have blood drawn before dialysis.
Target Population (High-Risk Groups):
-
Individuals aged 40 years and above
-
People with a family history of cancer
-
Individuals with risk factors related to diet or lifestyle
Not Suitable For:
-
Pregnant
-
Cancer patients who have been in remission for less than 3 years
-
Individuals who have undergone surgery, allogeneic bone marrow transplant, or blood transfusion within the past 2 weeks
- LucenceINSIGHT® Core
6 Core Cancer Screening:
Lung cancer, Colorectal cancer, Liver cancer, Pancreatic cancer, Breast cancer, Thyroid cancer
Price: $4,200
(Add on price after health checkup: $4,000) - LucenceINSIGHT® 12
12 Major Cancer Screening:
For Women:
-Thyroid Cancer
-Breast Cancer
-Liver Cancer
-Lung Cancer
-Pancreatic Cancer
-Colorectal Cancer
-Nasopharyngeal Cancer (EBV+)
-Stomach Cancer
-Gastrointestinal Stromal Tumor (GIST)
-Ovarian Cancer
-Cervical Cancer
-Endometrial Cancer
For Men:
-Thyroid Cancer
-Liver Cancer
-Lung Cancer
-Pancreatic Cancer
-Colorectal Cancer
-Nasopharyngeal Cancer (EBV+)
-Esophageal Cancer
-Stomach Cancer
-Kidney Cancer (Clear Cell)
-Gastrointestinal Stromal Tumor (GIST)
-Bladder Cancer
-Prostate Cancer
Price: $13,000
(Add-on price after health checkup: $12,350) - LucenceINSIGHT® 50
Detects up to 50 types of Cancer
Price: $23,000
(Add-on price after health checkup: $21,850)
Terms and Conditions
- The above prices do not include two doctor's consultation fees before and after the screening. The fee is $285 for Mondays to Saturdays and $395 for Sundays and public holidays.
- If patients wish to undergo this test during other consultation services, no additional consultation fees stated above are required.
- These cancer screenings are preliminary tests only. If a patient’s sample tests positive for cancer cell genes, thepatient may consider further examinations and treatment based on the doctor’s advice.
- This offer cannot be combined with other promotions.
- The Hospital reserves the final right to provide servicesand interpret the terms.
- This test does not assess inherited cancer risk and no genetic counseling is needed.
- This test is not a diagnostic test and positive results require follow-up testing.
- This test should complement but not replace routine screenings.
- This test detects only listed cancers and other cancers may still occur.
- Brain tumors are not included in the testdue to limited ctDNA + ctRNA release into circulation.
- False positives and false negatives can occur and annual testing is recommended.
Enquiries & Appointments
Tel: 2760 3420
WhatsApp